Primary Health Properties PLC
("PHP" or the "Company"),
Director/PDMR shareholding
The Company has today been notified that the following information relating to the transaction detailed below has been filed with the FCA in accordance with Article 19(1) of the Market Abuse Regulation
| 1 | Details of the person discharging managerial responsibilities/persons closely associated | ||
| (a) | Name | Mark Davies
| |
| 2 | Reason for notification | ||
| (a) | Position/Status | Chief Executive Officer, Designate | |
| (b) | Initial notification/amendment | Initial notification
| |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||
| (a) | Name | Primary Health Properties PLC | |
| (b) | LEI | 213800Y5CJHXOATK7X11
| |
| 4 | Details of the transaction(s): section to be repeated for: (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| (a) | Description of the financial instrument, type of instrument and identification code | Ordinary shares of 12.5p ISIN: GB00BYRJ5J14 | |
| (b) | Nature of transaction | Purchase | |
| (c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| £0.924 | 100,000 | ||
| (d) | Aggregated Information Aggregated volume price | Single transaction £92,400 | |
| (e) | Date of transaction | 6 March 2024
| |
| (f) | Place of transaction | London Stock Exchange (XLON)
| |
For further information:
Primary Health Properties PLC
Toby Newman, Company Secretary & Chief Legal Officer
+44(0) 7729 047 959
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
